Genomic Health, Inc. (GHDX) financial statements (2020 and earlier)

Company profile

Business Address 301 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063
State of Incorp.
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:2762141309795104105
Cash and cash equivalents72624640333033
Short-term investments2031488457627472
Other undisclosed cash, cash equivalents, and short-term investments04     
Receivables56523135373529
Other undisclosed current assets1391414111010
Total current assets:345275174146143149145
Noncurrent Assets
Operating lease, right-of-use asset50
Property, plant and equipment46404646402218
Long-term investments and receivables 4   1412
Long-term investments 4   1412
Other noncurrent assets191611921614
Other undisclosed noncurrent assets     (14)(12)
Total noncurrent assets:115605755423732
TOTAL ASSETS:460334232201185186177
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities53593941403527
Accounts payable6903975
Accrued liabilities151614109108
Employee-related liabilities32342528221813
Taxes payable     00
Debt5      
Customer refund liability     11
Deferred revenue and credits  001
Other liabilities0100000
Other undisclosed current liabilities    222
Total current liabilities:58604041433830
Noncurrent Liabilities
Long-term debt and lease obligation51      
Operating lease, liability51
Liabilities, other than long-term debt2444222
Other liabilities2444222
Total noncurrent liabilities:53444222
Total liabilities:111644345454032
Stockholders' equity
Stockholders' equity attributable to parent349270188156140146145
Common stock0000000
Treasury stock, value (30)(30)(30)(30)(30)(30)
Additional paid in capital538507465427395370345
Accumulated other comprehensive income (loss)0(0)(0)13(0)0
Accumulated deficit(189)(206)(246)(242)(228)(195)(170)
Total stockholders' equity:349270188156140146145
TOTAL LIABILITIES AND EQUITY:460334232201185186177

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues442394341328287276262
Revenue, net341328287276262
Cost of revenue(54)(49)(55)(57)(54)(49)(42)
Cost of goods and services sold  (55)(57)(54)(49)(42)
Gross profit:388345286271234227219
Operating expenses(332)(321)(292)(286)(268)(264)(244)
Other undisclosed operating income     1413
Operating income (loss):5624(6)(15)(34)(24)(12)
Nonoperating income (expense)424(0)(0)(1)(0)
Investment income, nonoperating5240000
Foreign currency transaction loss, before tax     (1)(0)
Other nonoperating income (expense)(1)(0)0(1)(0)(1)(0)
Interest and debt expense(0)      
Income (loss) from continuing operations before equity method investments, income taxes:6026(2)(16)(34)(25)(12)
Other undisclosed income (loss) from continuing operations before income taxes(2)1 3 1(0)
Income (loss) from continuing operations before income taxes:5827(2)(13)(34)(24)(12)
Income tax expense (benefit)(1)(1)(2)(1)1(0)(0)
Net income (loss) available to common stockholders, diluted:5726(4)(14)(33)(25)(13)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):5726(4)(14)(33)(25)(13)
Comprehensive income (loss):5726(4)(14)(33)(25)(13)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(1)(2)3(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:5726(5)(15)(31)(25)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: